Editorial
doi: 10.1016/j.cardfail.2022.10.421.
Improving outcomes in cardio-renal-metabolic diseases
Affiliations
- PMID: 36368805
- DOI: 10.1016/j.cardfail.2022.10.421
Item in Clipboard
Editorial
Improving outcomes in cardio-renal-metabolic diseases
J Card Fail.
2022 Nov.
No abstract available
Similar articles
-
Health Care Costs Associated with the Development and Combination of Cardio-Renal-Metabolic Diseases.Kidney360. 2023 Oct 1;4(10):1382-1388. doi: 10.34067/KID.0000000000000212. Epub 2023 Jul 18. Kidney360. 2023. PMID: 37461134 Free PMC article.
-
[Clinical and experimental data on the neurohumoral vascular and tissue effects of nialamide in cardiovascular and metabolic diseases].Chemotherapia (Basel). 1962;4:297-303. Chemotherapia (Basel). 1962. PMID: 14457226 German. No abstract available.
-
Improving quality in cardiometabolic medicine real-world evidence.Prim Care Diabetes. 2019 Apr;13(2):188. doi: 10.1016/j.pcd.2018.10.002. Epub 2018 Nov 13. Prim Care Diabetes. 2019. PMID: 30446359 No abstract available.
-
[Changes in cardiovascular risk factors and their impact].Nihon Rinsho. 2006 Aug;64 Suppl 6:91-5. Nihon Rinsho. 2006. PMID: 16981525 Review. Japanese. No abstract available.
-
Nonalcoholic fatty pancreatic disease and cardio-metabolic risk: is there is a place for obstructive sleep apnea?Cardiovasc Diabetol. 2014 Jan 30;13:29. doi: 10.1186/1475-2840-13-29. Cardiovasc Diabetol. 2014. PMID: 24475948 Free PMC article. Review.
Cited by
-
Genomic insights about the effect of sodium-glucose cotransporter 2 inhibitors: a systematic review.Front Genet. 2025 May 30;16:1571032. doi: 10.3389/fgene.2025.1571032. eCollection 2025. Front Genet. 2025. PMID: 40520225 Free PMC article.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
